Chemical compound
Pharmaceutical compound
Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.[1][2]
Mechanism of action
Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.[1]
References
- ^ a b “Pipenzolate”. Inxight Drugs. National Center for Advancing Translational Sciences.
- ^ Ivey KJ (January 1975). “Anticholinergics: do they work in peptic ulcer?”. Gastroenterology. 68 (1): 154–166. doi:10.1016/S0016-5085(75)80062-X. PMID 1090477.
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drugs for functional bowel disorders |
| ||||||||||||
| Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
| Propulsives | |||||||||||||